Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline
· onco3r therapeutics bv
AI Briefing
- Coultreon Biopharma raises $125M in Series A financing
- Led by Sofinnova Investments, with Forbion and Novo Holdings as co-leads
- To advance immunology pipeline
Advertisement